Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Feasibility, Usability and Acceptability of a Tablet-based Aphasia Therapy in the Acute Phase After Stroke

NCT03679637 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT03679637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03679637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Feasibility, Usability and Acceptability of a Tablet-based Aphasia Therapy in the Acute Phase After Stroke
Lead sponsor
University Hospital, Ghent
Phase
Not applicable
Overall status
Completed
Start date
September 28, 2018
Completion date
December 20, 2019
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aphasia, stroke, acute